ASLN250117P5000
- 0.00
- 0.000.00%
Aslan Pharmaceuticals Newsroom
Asian Equities Traded in the US as American Depositary Receipts Plummet in Monday Trading
Asian Equities Traded in the US as American Depositary Receipts Higher Friday, Index Down 2% for Week
Asian Equities Traded in the US as American Depositary Receipts Drop Sharply in Wednesday Trading
Asian Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading
Asian Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading
Asian Equities Traded in the US as American Depositary Receipts Fall in Friday Trading; Ends Week 4% Lower
Asian Equities Traded in US as American Depositary Receipts Rise in Thursday Trading
Top 3 Health Care Stocks Which Could Rescue Your Portfolio In July
ADRs Close Lower; Aslan Pharmaceuticals Ltd. Declines 37%
Why ASLAN Pharmaceuticals (ASLN) Shares Are Down 40%
Asian Equities Traded in the US as American Depositary Receipts Tumble in Wednesday Trading
ASLAN Stock Tumbles 54% After Board Votes to Liquidate
Wall Street Set to Open Lower Wednesday as Tech Stocks Take Hit
Top Premarket Decliners
ASLAN Pharmaceuticals Shares Are Trading Lower After the Company Announced That Its Singapore-incorporated, Sole Operating Subsidiary Has Filed for Voluntary Liquidation.
Press Release: ASLAN Pharmaceuticals Announces It Has Filed for Voluntary Liquidation of Its Sole Operating Subsidiary and Is Commencing Steps to Place Itself Into Voluntary Liquidation
Asian Equities Traded in the US as American Depositary Receipts Move Modestly Higher in Tuesday Trading
ADRs End Lower; Aslan Pharmaceuticals Ltd. Declines 46%
Aslan Pharma ADSs Fall 43%; Won't Appeal Nasdaq Delisting
Asian Equities Traded in the US as American Depositary Receipts Open Week Lower in Monday Trading